Home › Non-Small Cell Lung Cancer › Illinois › Cicero
Non-Small Cell Lung Cancer clinical trials in Cicero, IL
24 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RecruitingPhase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi away
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi away
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- Hope and Healing Cancer Services, Hinsdale · 10 mi away
- Endeavor Health, Elmhurst · 10 mi away
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RecruitingPhase 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi away
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RecruitingPhase 3
- Research Site, Hinsdale · 10 mi away
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RecruitingPhase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi away
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Research Site, Hinsdale · 10 mi away
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Loyola University Medical Center, Maywood · 5 mi away
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecruitingPhase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi away
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi away
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RecruitingPhase 3
- Research Site, Hinsdale · 10 mi away
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 3
- Research Site, Hinsdale · 10 mi away
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RecruitingPhase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi away
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Loyola University Medical Center, Maywood · 5 mi away
- and 2 more
MYLUNG Consortium Part 3: Observational Study
RecruitingObservational study
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Loyola University Medical Center, Maywood · 5 mi away
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
- and 3 more
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Loyola University Medical Center, Maywood · 5 mi away
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- and 2 more
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi away
- Loyola University Medical Center, Maywood · 5 mi away
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi away
- Advocate High Tech Medical Park, Palos Heights · 12 mi away
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Recruiting
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi away
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- Hope and Healing Cancer Services, Hinsdale · 10 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Cicero
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Metastatic Cancer7 studies
- Multiple Myeloma6 studies
- Burkitt Lymphoma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.